Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Adc Therapeutics Sa
(NY:
ADCT
)
4.720
-0.040 (-0.84%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
646,031
Open
4.760
Bid (Size)
4.600 (10)
Ask (Size)
4.820 (1)
Prev. Close
4.760
Today's Range
4.600 - 4.920
52wk Range
0.3599 - 6.040
Shares Outstanding
76,721,543
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
April 04, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
April 03, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
Performance
YTD
+179.29%
+179.29%
1 Month
-0.21%
-0.21%
3 Month
+159.34%
+159.34%
6 Month
+468.67%
+468.67%
1 Year
+111.66%
+111.66%
More News
Read More
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
April 01, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
A Preview Of ADC Therapeutics's Earnings
March 12, 2024
Via
Benzinga
ADC Therapeutics - Time For A Turn-Around?
February 27, 2024
Via
Talk Markets
Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
March 13, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
March 13, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
March 06, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024
March 06, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
Analyst Expectations for ADC Therapeutics's Future
November 20, 2023
Via
Benzinga
Earnings Scheduled For March 13, 2024
March 13, 2024
Via
Benzinga
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday
February 20, 2024
Via
Benzinga
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
February 08, 2024
Via
InvestorPlace
ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
January 04, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics Provides Business Updates
January 04, 2024
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evaluating ZYNLONTA® in Combination with Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
December 12, 2023
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics Receives NYSE Notice of Non-Compliance With Continued Listing Standards
November 07, 2023
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 07, 2023
From
ADC Therapeutics SA
Via
GlobeNewswire
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
November 06, 2023
Via
Benzinga
ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
November 06, 2023
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting
November 02, 2023
From
ADC Therapeutics SA
Via
GlobeNewswire
ADC Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on November 7, 2023
October 24, 2023
From
ADC Therapeutics SA
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.